Hard to argue against the tailwinds in petcare
Pairing inelastic demand (i.e., growing humanization of pets)…
… with a large user base (& growing)…
… across a highly fragmented provider market
Its a powerful wave to ride + the tsunami is only picking up momentum
🚨Call for Operators🚨
For much of 2021 I've been developing a new idea for entrepreneurship through acquisition (EtA) with a partner. We're not quite ready to pull back the curtains, but we're really close.
1/6
Great overview on different financing structures
Creativity in deal structuring is often times the reason a deal does (or doesn’t) get done
Part of the ‘art’ is aligning incentives in a way that optimizes for what matters most to each person:
You want to invest in a private company via direct investment.
i.e. you're investing into a new or existing venture directly -- not through a sponsor or fund.
How do you get paid?
Here's a thread on all the structures I've seen.
1/x
A real differentiator among those I’ve worked/partnered with:
The best run toward the hard things… not away from them
This applies to work, personal, or otherwise. But it’s a muscle that is built, not inherited
@jspujji Great pod
The two big trends I spend a lot of time on:
1-software being built on top of existing PIMS (practice mgt systems) for services side…very early innings here
2-consumer 2.0/those building the One Meds & Tends of the world across diff components of petcare value chain
Taxes... we all gotta pay 'em on both our labor & our investment returns.
But Section 1202/Qualified Small Business Stock (QSBS) can help you avoid 100% of capital gains tax on the sale of QSBS.
This holds in both the SMB world & for angel investors/VCs.
How this works 👇
Hard to argue against the tailwinds in petcare
Pairing inelastic demand (i.e., growing humanization of pets)…
… with a large user base (& growing)…
… across a highly fragmented provider market
Its a powerful wave to ride + the tsunami is only picking up momentum
@BrettAHolloway@lmmceo@Clearingfog_ Depends… on clinic (GP vs. Specialty and/or ER) and market (Top 10 MSA or not)
No doubt multiples are high for majority of single sites (>10x) but a small clinic strategy in Midwest trades diff than urban core play
@Clearingfog_ No doubt expensive for existing clinics, but prob some value to be had for rolling up a bunch of 1-2 DVM practices for <10x if can de-risk/grow offering
Even better though… do de novo model where you build for <2x maturity clinic-level EBITDA & get platform value of >20x :)
@mstillwell8 Lots of runway… although can be hard to compete w/ the big players who have multiple product lines (home, auto, etc) and can underwrite a huge CAC given LTV of a new cust
@bshyong I spend a lot of time in vet services across diff pieces of value chain:
- vet clinics (GP/ER/Specialty)
- daycare/boarding
- tele
- practice mgt saas
- aftercare/hospice
- lab/diagnostics
So Idexx/Petco/Chewy are tangential & public (but also seen quite a bit of appreciation)